Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2015 1
2016 1
2017 1
2019 1
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation.
Okumura K, Akao M, Yoshida T, Kawata M, Okazaki O, Akashi S, Eshima K, Tanizawa K, Fukuzawa M, Hayashi T, Akishita M, Lip GYH, Yamashita T; ELDERCARE-AF Committees and Investigators. Okumura K, et al. N Engl J Med. 2020 Oct 29;383(18):1735-1745. doi: 10.1056/NEJMoa2012883. Epub 2020 Aug 30. N Engl J Med. 2020. PMID: 32865374 Clinical Trial.
Prasugrel effectively reduces the platelet reactivity units in patients with genetically metabolic dysfunction of cytochrome P450 2C19 who are treated with long-term dual antiplatelet therapy after undergoing drug-eluting stent implantation.
Shimamatsu J, Sasaki KI, Katsuki Y, Kawasaki T, Murasato Y, Ajisaka H, Yokoi H, Tashiro H, Harada A, Hirakawa Y, Ishizaki Y, Ishimatsu T, Kagiyama K, Fukumoto Y, Kakuma T, Ueno T. Shimamatsu J, et al. Heart Vessels. 2020 Mar;35(3):312-322. doi: 10.1007/s00380-019-01499-7. Epub 2019 Sep 23. Heart Vessels. 2020. PMID: 31549178 Free PMC article. Clinical Trial.
Changes in P2Y12 reaction units after switching treatments from prasugrel to clopidogrel in Japanese patients with acute coronary syndrome followed by elective coronary stenting.
Ueno T, Koiwaya H, Sasaki KI, Katsuki Y, Katsuda Y, Murasato Y, Shimamatsu J, Umeji K, Otsuka Y, Kawasaki T, Shibata Y, Fukumoto Y. Ueno T, et al. Among authors: shimamatsu j. Cardiovasc Interv Ther. 2017 Oct;32(4):341-350. doi: 10.1007/s12928-016-0417-x. Epub 2016 Aug 3. Cardiovasc Interv Ther. 2017. PMID: 27488859 Clinical Trial.
Analysis of unilateral adrenal hyperplasia with primary aldosteronism from the aspect of messenger ribonucleic acid expression for steroidogenic enzymes: a comparative study with adrenal cortices adhering to aldosterone-producing adenoma.
Shigematsu K, Kawai K, Irie J, Sakai H, Nakashima O, Iguchi A, Shimamatsu J, Shimamatsu K, Kusaba Y, Takahara O. Shigematsu K, et al. Among authors: shimamatsu j. Endocrinology. 2006 Feb;147(2):999-1006. doi: 10.1210/en.2005-0765. Epub 2005 Nov 10. Endocrinology. 2006. PMID: 16282357